8 min read
November Keystone Symposia Fellow's Spotlight on Dr. Novalia Pishesha
Our November Fellow’s Spotlight showcases Dr. Novalia Pishesha, an assistant professor of pediatrics with appointments...
Due to an inherent fascination with parasitic helminthes, De’Broski R. Herbert earned a B.S. in Microbiology from Xavier University of Louisiana (1994) and a Ph.D. in Immunology from Thomas Jefferson Medical College (2000). His thesis work demonstrated a critical role for IL-5, B-1 lymphocytes, and eosinophils in host-protective immunity against Strongyloides stercoralis (J Immunol. 2000 Oct 15;165(8):4544-51).
As part of a life-long dream, De’Broski spent several years in South Africa to complete his post-doctoral training at the University of Cape Town in the laboratory of Frank Brombacher Ph.D. This resulted in seminal work that demonstrated IL-4/IL-13-driven alternative macrophage activation controls lethal immunopathology during Schistosoma mansoni infection (Immunity. 2004 May;20 (5):623-35).
Subsequently, he joined the laboratory of Fred. D. Finkelman M.D. and published multiple studies focused on the importance of IL-4/IL-13 in driving host-protection against parasitic helminthes through direct regulation of tissue macrophage function (J Immunol. 2010 Jun 1;184(11):6438-46) and mucosal epithelia (J Exp Med. 2009 Dec 21;206(13):2947-57).
As principal investigator of his independent laboratory at Cincinnati Children’s Research Foundation, his work focused upon elucidating mechanisms of innate Type 2 cytokine regulation by Trefoil factor family proteins (J Exp Med. 2012 Mar 12;209 (3):607-22) and immunosuppressivemacrophage subsets in the context of helminth infection and allergic inflammation (Eur J Immunol. 2011 Jul;41(7):2000-9,
Am J Pathol. 2012 May;180(5):2001-8).
As a Professor of Immunology, Department of Microbiology/Immunology, Tulane University School of Medicine, Dr. Herbert studies how IL-33, a key immune molecule, influences inflammation, tissue repair, and allergic diseases. His research reveals how myeloid-derived IL-33 drives type 2 immune responses, shaping how our bodies react to parasites, lung disease, and gut inflammation.
His recent work has uncovered how IL-33 can act as both an inflammatory trigger and a healing signal, offering new insights into treating asthma, allergies, and chronic inflammatory conditions.
Research Area(s):
CancerResearch Keywords:
Mentor: ,
Nov 25, 2025 by Keystone Symposia
Our November Fellow’s Spotlight showcases Dr. Novalia Pishesha, an assistant professor of pediatrics with appointments...
Oct 28, 2025 by Keystone Symposia
Our October Keystone Symposia Fellow's Spotlight features Dr. Brea Manuel, a post-doctoral researcher at the University...